Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Gourang P Patel, Jaime Simon Grahe, Mathew Sperry...
https://pubmed.ncbi.nlm.nih.gov/19851126Completed
Led by Rush University Medical Center · Updated on 2023-01-11
252
Participants Needed
1
Research Sites
N/A
Total Duration
We are performing a prospective, randomized, controlled trial of dopamine versus norepinephrine for septic shock. The trial will enroll patients with suspected or documented site of infection and having 2 out of the three SIRS criteria. Patients will also be receiving standard of care, early-goal directed therapy including but not limited to fluid resuscitation, appropriate and early antibiotics, source control and evaluation for drotrecogin alpha where deemed appropriate, while being supported for septic shock.
CONDITIONS
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
You may qualify if you...
You will not qualify if you...
Total: 1 location
1
RUSH University Medical Center
Chicago, Illinois, United States, 60612
Status Unknown
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Gourang P Patel, Jaime Simon Grahe, Mathew Sperry...
https://pubmed.ncbi.nlm.nih.gov/19851126